LifePoint Financial Statements From 2010 to 2025
LifePoint's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LifePoint's valuation are provided below:LifePoint does not presently have any fundamental ratios for analysis.
This module can also supplement various LifePoint Technical models . Check out the analysis of LifePoint Correlation against competitors.
Check LifePoint financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifePoint's main balance sheet or income statement drivers, such as , as well as many indicators such as . LifePoint financial statements analysis is a perfect complement when working with LifePoint Valuation or Volatility modules.
LifePoint |
LifePoint Company Return On Asset Analysis
LifePoint's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current LifePoint Return On Asset | -0.74 |
Most of LifePoint's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LifePoint is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, LifePoint has a Return On Asset of -0.7382. This is 91.56% lower than that of the Health Care Providers & Services sector and 97.46% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
LifePoint Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LifePoint's current stock value. Our valuation model uses many indicators to compare LifePoint value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LifePoint competition to find correlations between indicators driving LifePoint's intrinsic value. More Info.LifePoint is rated third overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value LifePoint by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LifePoint's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About LifePoint Financial Statements
Investors use fundamental indicators, such as LifePoint's revenue or net income, to determine how well the company is positioned to perform in the future. Although LifePoint's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. The company was incorporated in 1992 and is based in Ontario, California. Lifepoint operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 52 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in LifePoint Pink Sheet
LifePoint financial ratios help investors to determine whether LifePoint Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LifePoint with respect to the benefits of owning LifePoint security.